Karyopharm Therapeutics Inc. (KPTI) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$649
Total Return
-93.51%
CAGR
-42.14%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -1.68% |
| Median | -5.04% |
| Best | +101.95% |
| Worst | -55.75% |
| % of Windows Positive | 39.8% |
1-Year (252 Trading Days)
| Average | -42.66% |
| Median | -52.31% |
| Best | +119.77% |
| Worst | -87.62% |
| % of Windows Positive | 10.7% |
3-Year (756 Trading Days)
| Average | -89.44% |
| Median | -90.40% |
| Best | -73.81% |
| Worst | -96.79% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -98.36% |
| Average Drawdown | -78.16% |
| Drawdown Duration | 1074 Trading Days (Unrecovered) |
| Sortino Ratio | -0.16 |
| Calmar Ratio | -0.43 |
| CVaR (5%) | -12.29% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +22.28% (+61.14% ann.) | +$2228.26 | $0.00 | $0.00 | $0.00 |
| 2025 | -27.42% | $2741.58 | $0.00 | $0.00 | $0.00 |
| 2024 | -21.85% | $2185.03 | $0.00 | $0.00 | $0.00 |
| 2023 | -74.56% | $7455.89 | $0.00 | $0.00 | $0.00 |
| 2022 | -47.12% | $4712.29 | $0.00 | $0.00 | $0.00 |
| 2021 | -58.46% | $5846.25 | $0.00 | $0.00 | $0.00 |
| 2020 | -19.25% | $1924.88 | $0.00 | $0.00 | $0.00 |
| 2019 | +104.59% | +$10458.89 | $0.00 | $0.00 | $0.00 |
| 2018 | -2.40% | $239.58 | $0.00 | $0.00 | $0.00 |
| 2017 | +2.13% | +$212.76 | $0.00 | $0.00 | $0.00 |
| 2016 | -29.06% | $2905.66 | $0.00 | $0.00 | $0.00 |
| 2015 | -64.60% | $6460.06 | $0.00 | $0.00 | $0.00 |
| 2014 | +63.31% | +$6330.72 | $0.00 | $0.00 | $0.00 |
| 2013 partial | +42.80% (+965.64% ann.) | +$4280.37 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | November 6, 2013 – February 19, 2020 | +1.68% | +0.27% | +$168.22 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | +11.40% | +242.73% | +$1139.55 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -30.12% | -43.83% | $3012.34 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -53.02% | -51.16% | $5301.79 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -22.16% | -23.35% | $2215.82 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -86.93% | -66.65% | $8693.38 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -18.59% | -11.36% | $1858.93 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.